AZothBio (에이조스바이오)

Based on the AI-BIO platform has established the new drug development platform for compound screening such as new small molecules, macromolecules such as peptides and proteins, and phenotype-based anticancer compounds, and for predicting the suitability of new drugs. We want to contribute to the advancement of medical care by minimizing the time required to develop new drugs for pharmaceutical companies, bio-ventures, and patients.Based on the AI-BIO platform has established the new drug development platform for compound screenin Show More

Alpha Score

62.7

Total Funding$ 5.85 M